Dermatology Resident

Jeffrey is from Washington State and attended the University of Washington for undergraduate. There he joined the laboratory of Charles Chavkin, studying how the kappa opioid receptor regulates stress and addiction. He subsequently matriculated in the MD/PhD program at Duke University, studying chemokine receptor signaling and biased agonism under the mentorship of Sudar Rajagopal and Robert Lefkowitz. After completing an intern year in medicine, Jeffrey joined the Harvard Combined Dermatology Residency Program as part of an integrated physician-scientist pathway and where he cares for patients with complex skin diseases. He joined the Kruse Lab in 2022 and is studying noncanonical GPCR signaling pathways.